As Covid rises again, killing about 1,500 Americans each week, medical researchers are trying to understand why so few people are taking Paxlovid, a medicine that is stunningly effective in preventing severe illness and death from the disease.
Gun violence in America is increasing, not only on crowded city streets, but in small towns in remote parts of the country that lack resources to save people from life-threatening gunshot wounds. ...
The group believes doctors received bonuses and incentives for giving medications, like remdesivir, to sick family members. They claim their loved ones got worse after receiving the medication....
A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.
Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XCQKBP276JLAHLGPQMCTFXFYGQ.jpg)
